Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2018

Open Access 01-12-2018 | Case report

Walking hyponatremia syndrome of inappropriate antidiuretic hormone secretion secondary to carbamazepine use: a case report

Authors: Pedro José Palacios Argueta, Guillermo Francisco Sánchez Rosenberg, Alvaro Pineda

Published in: Journal of Medical Case Reports | Issue 1/2018

Login to get access

Abstract

Background

Severe hyponatremia is rare when carbamazepine is used as monotherapy. It is common to encounter this imbalance in the hospital setting, but rare in the ambulatory one. Here, we present a case of hyponatremia secondary to carbamazepine use in an otherwise asymptomatic patient.

Case presentation

A 44-year-old Guatemalan woman presented to our outpatient clinic with a chief complaint of left knee pain. One month prior, our patient had previously consulted with an outside physician, who prescribed her with 300 mg of carbamazepine, 5 mg of prednisone every 24 hours, and ibuprofen every 8 hours as needed. The symptoms did not resolve and our patient had increased the dose to 600 mg of carbamazepine and 20 mg of prednisone 7 days prior. Our patient complained of left knee pain, fatigue, and bilateral lower limb cramps. No pertinent medical history was recorded and her vital signs were within normal limits. A physical examination was non-contributory, only multiple port-wine stains in the upper and lower extremities associated with mild hypertrophy of the calves, more prominent on the right side. Laboratory studies revealed: a serum sodium level of 119 mmol/L, potassium level of 2.9 mmol/L, thyroid-secreting hormone of 1.76 mIU/m, thyroxine of 14.5 ng/dL, and serum osmolality at 247 mmol/kg. No neurologic or physical disabilities were recorded. In the emergency department, her electrolyte imbalance was corrected and other diagnostic studies revealed: a urinary sodium level of 164 mmol/L and osmolality at 328 mmol/kg. Our patient was diagnosed with syndrome of inappropriate antidiuretic hormone secretion secondary to carbamazepine use, hypokalemia secondary to corticosteroid therapy, and Klippel-Trénaunay-Weber syndrome. Carbamazepine was discontinued, fluid restriction ordered, and hypokalemia was corrected. One week after discharge, our patient no longer felt fatigued, the cramps were not present, and her left knee pain had mildly improved with acetaminophen use and local nonsteroidal anti-inflammatory cream. Electrolyte studies revealed a sodium level of 138 mmol/L, potassium level of 4.6 mmol/L, and serum osmolality at 276 mmol/L.

Conclusions

Hyponatremia can be misdiagnosed if not recognized promptly; suspicion should be high when risk factors are present and the patient has been prescribed antiepileptic drugs. Presence of mild symptoms such as fatigue or dizziness should lead to suspicion and subsequent laboratory testing. Patients can suffer from neurologic complications if the imbalance is not corrected.
Literature
2.
go back to reference Goh KP. Management of hyponatremia. Am Fam Physician. 2004;69:2387–94.PubMed Goh KP. Management of hyponatremia. Am Fam Physician. 2004;69:2387–94.PubMed
3.
go back to reference Lu X, et al. Hyponatremia induced by antiepileptic drugs in patients with epilepsy. Expert Opin Drug Saf. 2017;16(1):77–87.CrossRefPubMed Lu X, et al. Hyponatremia induced by antiepileptic drugs in patients with epilepsy. Expert Opin Drug Saf. 2017;16(1):77–87.CrossRefPubMed
4.
5.
go back to reference Bragança AC, et al. Carbamazepine can induce kidney water absorption by increasing aquaporin 2 expression. Nephrol Dial Transplant. 2010;25:3840–5.CrossRefPubMed Bragança AC, et al. Carbamazepine can induce kidney water absorption by increasing aquaporin 2 expression. Nephrol Dial Transplant. 2010;25:3840–5.CrossRefPubMed
7.
go back to reference Letmaier M, et al. Hyponatraemia during psychopharmacological treatment: results of a drug surveillance programme. Int J Neuropsychopharmacol. 2012;15(6):739–48.CrossRefPubMed Letmaier M, et al. Hyponatraemia during psychopharmacological treatment: results of a drug surveillance programme. Int J Neuropsychopharmacol. 2012;15(6):739–48.CrossRefPubMed
8.
go back to reference Kuz GM, et al. Carbamazepine-induced hyponatremia:assessment of risk factors. Ann Pharmacother. 2005;39(11):1943–6.CrossRefPubMed Kuz GM, et al. Carbamazepine-induced hyponatremia:assessment of risk factors. Ann Pharmacother. 2005;39(11):1943–6.CrossRefPubMed
9.
go back to reference Pliquett RU, et al. Endocrine testing for the syndrome of inappropriate antidiuretic hormone secretion (SIADH). [Updated 2017 Apr 16]. In: De Groot LJ, Chrousos G, Dungan K, et al., editors. Endotext [Internet]. South Dartmouth: MDText.com, Inc.; 2000. Pliquett RU, et al. Endocrine testing for the syndrome of inappropriate antidiuretic hormone secretion (SIADH). [Updated 2017 Apr 16]. In: De Groot LJ, Chrousos G, Dungan K, et al., editors. Endotext [Internet]. South Dartmouth: MDText.com, Inc.; 2000.
10.
go back to reference Braun MM, et al. Diagnosis and Management of Sodium Disorders: hyponatremia and hypernatremia. Am Fam Physician. 2015;91(5):299–307.PubMed Braun MM, et al. Diagnosis and Management of Sodium Disorders: hyponatremia and hypernatremia. Am Fam Physician. 2015;91(5):299–307.PubMed
11.
go back to reference Spasovski G, Hyponatraemia guideline development group, et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Eur J Endocrinol. 2014;170(3):G1–G47.CrossRefPubMed Spasovski G, Hyponatraemia guideline development group, et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Eur J Endocrinol. 2014;170(3):G1–G47.CrossRefPubMed
12.
go back to reference Verbalis JG, et al. Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. Am J Med. 2013;126(10 suppl 1):S1–S42.CrossRefPubMed Verbalis JG, et al. Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. Am J Med. 2013;126(10 suppl 1):S1–S42.CrossRefPubMed
Metadata
Title
Walking hyponatremia syndrome of inappropriate antidiuretic hormone secretion secondary to carbamazepine use: a case report
Authors
Pedro José Palacios Argueta
Guillermo Francisco Sánchez Rosenberg
Alvaro Pineda
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2018
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-018-1744-6

Other articles of this Issue 1/2018

Journal of Medical Case Reports 1/2018 Go to the issue